Search research articles
Contact Us
Filters
Showing results (81-90 of 92) with videos related to
Page
of 10
Sort By:
Cancers
|
June 24, 2020
The Quality of Practice Guidelines for Melanoma: A Methodologic Appraisal with the AGREE II and AGREE-REX Instruments
Theresa Steeb, Anja Wessely, Konstantin Drexler, et al.
Cancers
|
October 21, 2020
Arthralgia Induced by BRAF Inhibitor Therapy in Melanoma Patients
Martin Salzmann, Karolina Benesova, Kristina Buder-Bakhaya, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 4, 2020
Programmed cell death protein 1 inhibitors in advanced cutaneous squamous cell carcinoma: real-world data of a retrospective, multicenter study
Martin Salzmann, Ulrike Leiter, Carmen Loquai, et al.
Cancers
|
March 11, 2023
Tolerability of BRAF and MEK Inhibitors for Metastasized Melanoma after Intra-Class Switch: A Multicenter, Retrospective Study
Martin Salzmann, Alexander Wald, Henner Stege, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 10, 2022
MEK inhibitors for pre-treated, NRAS-mutated metastatic melanoma: A multi-centre, retrospective study
Martin Salzmann, Johannes Pawlowski, Carmen Loquai, et al.
Trials
|
April 21, 2021
Development and validation of a web-based patient decision aid for immunotherapy for patients with metastatic melanoma: study protocol for a multicenter randomized trial
Pia Grabbe, Kathrin M Gschwendtner, Imad Maatouk, et al.
Oncoimmunology
|
April 28, 2022
Evaluation of radio-immunotherapy sequence on immunological responses and clinical outcomes in patients with melanoma brain metastases (ELEKTRA)
Jessica C Hassel, Timo E Schank, Heiko Smetak, et al.
Cancers
|
November 26, 2022
Response to First-Line Treatment with Immune-Checkpoint Inhibitors in Patients with Advanced Cutaneous Squamous Cell Carcinoma: A Multicenter, Retrospective Analysis from the German ADOReg Registry
Maximilian Haist, Henner Stege, Berenice Mareen Lang, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 11, 2021
Hematological immune related adverse events after treatment with immune checkpoint inhibitors
Rafaela Kramer, Anne Zaremba, Alvaro Moreira, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 26, 2022
Characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis: A retrospective multicentre cohort study
Leonie Müller-Jensen, Sarah Zierold, Judith M Versluis, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 92) with videos related to
Sort By:
Page
of 10
Cancers
|
June 24, 2020
The Quality of Practice Guidelines for Melanoma: A Methodologic Appraisal with the AGREE II and AGREE-REX Instruments
Theresa Steeb, Anja Wessely, Konstantin Drexler, et al.
Cancers
|
October 21, 2020
Arthralgia Induced by BRAF Inhibitor Therapy in Melanoma Patients
Martin Salzmann, Karolina Benesova, Kristina Buder-Bakhaya, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 4, 2020
Programmed cell death protein 1 inhibitors in advanced cutaneous squamous cell carcinoma: real-world data of a retrospective, multicenter study
Martin Salzmann, Ulrike Leiter, Carmen Loquai, et al.
Cancers
|
March 11, 2023
Tolerability of BRAF and MEK Inhibitors for Metastasized Melanoma after Intra-Class Switch: A Multicenter, Retrospective Study
Martin Salzmann, Alexander Wald, Henner Stege, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 10, 2022
MEK inhibitors for pre-treated, NRAS-mutated metastatic melanoma: A multi-centre, retrospective study
Martin Salzmann, Johannes Pawlowski, Carmen Loquai, et al.
Trials
|
April 21, 2021
Development and validation of a web-based patient decision aid for immunotherapy for patients with metastatic melanoma: study protocol for a multicenter randomized trial
Pia Grabbe, Kathrin M Gschwendtner, Imad Maatouk, et al.
Oncoimmunology
|
April 28, 2022
Evaluation of radio-immunotherapy sequence on immunological responses and clinical outcomes in patients with melanoma brain metastases (ELEKTRA)
Jessica C Hassel, Timo E Schank, Heiko Smetak, et al.
Cancers
|
November 26, 2022
Response to First-Line Treatment with Immune-Checkpoint Inhibitors in Patients with Advanced Cutaneous Squamous Cell Carcinoma: A Multicenter, Retrospective Analysis from the German ADOReg Registry
Maximilian Haist, Henner Stege, Berenice Mareen Lang, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 11, 2021
Hematological immune related adverse events after treatment with immune checkpoint inhibitors
Rafaela Kramer, Anne Zaremba, Alvaro Moreira, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 26, 2022
Characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis: A retrospective multicentre cohort study
Leonie Müller-Jensen, Sarah Zierold, Judith M Versluis, et al.
Page
of 10